This article is more than 5 years old. Information may no longer be current.

VIDEO: Results from MONALEESA-2 represent ‘exciting update’ for metastatic breast cancer

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — The phase 3 MONALEESA-2 trial was “a very interesting study,” according to  Jane Meisel, MD, a medical oncologist at the Winship Cancer Institute and an assistant professor in the department of hematology and medical oncology at Emory University School of Medicine.

“The combination of ribociclib and letrozole, when compared with letrozole alone, improved PFS significantly,” she said.

Results of the trial may impact dosing schedules as well as cost, according to Meisel.